A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/05 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2658632
Elderly individuals are administered dosages of Trans-resveratrol totaling between about 250 mg and 1 gram per day. Typically about 500 mg of Trans-resveratrol are orally administered to such individuals on a daily basis. As a result of the chemical action of Trans-resveratrol in the bodies of the subjects, Alzheimer's disease is prevented, or if already present, advancement is retarded and the existing mentally debilitating conditions of Alzheimer's disease are treated. A subject receiving the Trans-resveratrol experiences a reduction or illumination of the effects of Alzheimer's disease.
Des personnes âgées reçoivent des dosages de trans-resvératrol qui totalisent entre environ 250 mg et 1 gramme par jour. Typiquement, environ 500 mg de trans-resvératrol sont administrés par voie orale à ces personnes quotidiennement. En conséquence de l'action chimique du trans-resvératrol dans les corps des sujets, la maladie d'Alzheimer est évitée, ou si elle est déjà présente, sa progression est retardée et les états de déficience mentale existants de la maladie d'Alzheimer sont traités. Un sujet recevant le trans-resvératrol connaît une réduction ou une suppression des effets de la maladie d'Alzheimer.
Toppo Frank
Toppo Robert
Hill & Schumacher
Toppo Frank
Toppo Robert
LandOfFree
Method for prevention and treatment of alzheimers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for prevention and treatment of alzheimers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for prevention and treatment of alzheimers will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1934472